Changes in sodium, potassium-ATPase induced by repeated fencamfamine: The roles of cyclic AMP-dependent protein kinase and the nitric oxide-cyclic GMP pathway

Neuropharmacology

Volumn 45, Issue 8, 2003, Pages 1151-1159

  Munhoz, Carolina Demarchi ^a   Glezer, Isaias ^a   Kawamoto, Elisa Mitiko ^a   Natalini Araújo, Ana Paula ^b   Lepscha, Lucília B ^b   Planeta, Cleopatra S ^b   DeLucia, Roberto ^a   Scavone, Cristoforo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Cyclic GMP; Fencamfamine; Glutamate; Na,K ATPase; Nitric oxide synthase; PKA

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; FENCAMFAMIN; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0242408382     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(03)00278-8     Document Type: Article

References (39)

1. Araujo A.P.N., DeLucia R., Scavone C., Planeta C.S. Repeated predictable and unpredictable stress: effects on cocaine-induced locomotion and cyclic AMP-dependent protein kinase activity. Behavioural Brain Research. 139:2003;75-81.
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
3. Byrnes J.J., Pantke M.M., Onton J.A., Hammer R.P. Jr. Inhibition of nitric oxide synthase in the ventral tegmental area attenuates cocaine sensitization in rats. Progress in Neuropsychopharmacology and Biological Psychiatry. 24:(2):2000;261-273.
4. Cepeda C., Buchwald N.A., Levine M.S. Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proceedings of the National Academy of Sciences (PNAS). 90:1993;9576-9580.
5. Covington H.E. III, Miczek K.A. Repeated social defeat stress or morphine: effects on behavioral sensitization and IV cocaine self-administration "binges" Psychopharmacology (Berl). 158:2001;388-398.
6. Cunningham S.T., Kelley A.E. Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the NAc. Journal of Neuroscience. 13:1993;2342-2350.
7. DeLucia R., Planeta C.S. Fencamfamine (minireview). General Pharmacology. 21:1990;161-163.
8. DeLucia R., Bernardi M.M., Scavone C., Aizenstein M.L. On the mechanism of central stimulant action of fencamfamine. General Pharmacology. 15:1984;407-410.
9. 18 occurs in intact cells but does not result in direct inhibition of ATP hydrolysis. Journal of Biological Chemistry. 272:1997;17726-17733.
10. Fienberg A.A., Hiroi N., Mermelstein P.G., Song W.J., Snyder G.L., Nishi A., Cheramy A., O'Callaghan J.P., Miller D.B., Cole D.G., Corbett R., Haile C.N., Cooper D.C., Onn S.P., Grace A.A., Ouimet C.C., White F.J., Hyman S.E., Surmeier D.J., Girault A.A., Nestler E.J., Greengard P. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science. 281:1998;838-842.
11. Garthwaite J., Boulton C.L. Nitric oxide signaling in the central nervous system. Annual Review of Physiology. 57:1995;683-706.
12. Gloor S.M. Relevance of Na,K-ATPase to local extracellular potassium homeostasis and modulation of synaptic transmission. FEBS Letters. 412:1997;1-4.
13. Greengard P., Nairn A.C., Girault J.-A., Ouimet C.C., Snyder G.L., Fisone G., Allen P.B., Fienberg A., Nishi A. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration. Brain Research Reviews. 26:1998;274-284.
14. Haracz J.L., MacDonall J.S., Sircar R. Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Research. 746:(1-2):1997;183-189.
15. Kalivas P.N., Stewart J. Dopamine transmission in the initiation and expression of drug and stress-induced sensitization of motor activity. Brain Research Reviews. 16:1991;223-244.
16. Kleven M.S., Perry B.D., Woolverton W.L., Seiden L.S. Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Research. 532:1990;265-270.
17. Konradi C. The molecular basis of dopamine and glutamate interactions in the striatum. Advances in Pharmacology. 42:1998;729-733.
18. Kuczensky R., Segal D.S., Aizenstein M.L. Amphetamine, cocaine and fencamfamine: relationship between locomotor and stereotype response profiles and caudate and accumbens dopamine dynamics. Journal of Neuroscience. 11:1991;2703-2712.
19. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiology Review. 71:1991;155-234.
20. Lonart G., Cassels K.L., Johnson K.M. Nitric oxide induces calcium-dependent [3H]-dopamine release from striatal slices. Journal of Neuroscience Research. 35:1993;192-198.
21. McKee M., Scavone C., Nathanson J.A. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proceedings of the National Academy of Sciences (PNAS). 91:1994;12056-12060.
22. Nathanson J.A., Scavone C., Scanlon C., McKee M. The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity. Neuron. 14:1995;781-794.
23. Ortiz J., Fitzgerald L.W., Lane S., Terwillinger R., Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology. 14:1996;443-452.
24. Peris J., Boyson S.J., Cass W.A., Curella P., Dwoskin L.P., Larson G., Lin L.H., Yasuda R.P., Zahniser N.R. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. Journal of Pharmacology and Experimental Therapeutics. 253:1990;38-44.
25. Pinto Ferreira M., DeLucia R., Aizenstein M.L., Glezer I., Scavone C. Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum. Journal of Neural Transmission. 105:1998;549-560.
26. Planeta C.S., DeLucia R., Aizenstein M.L. The behavioral sensitization induced by fencamfamine is not related to plasma drug levels. Brazilian Journal of Medical and Biological Research. 28:1995a;667-670.
27. Planeta C.S., DeLucia R., Aizenstein M.L. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors. Pharmacology Biochemistry and Behavior. 50:(1):1995b;35-40.
28. Pontiggia L., Winterhalter K., Gloor S.M. Inhibition of Na,K-ATPase activity by cGMP is isoform-specific in brain endothelial cells. FEBS Letters. 436:1998;466-470.
29. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Research Reviews. 396:1986;157-198.
30. Robinson T.E., Berridge K.C. The neural basis of drug craving: an incentive salience theory of addiction. Brain Research Reviews. 18:1993;247-291.
31. Salinovich O., Montelaro R. Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by SDS-PAGE. Analytical Biochemistry. 156:1986;341-347.
32. Segal D.S., Kuczenski R. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Research. 577:1992;351-355.
33. Steiner A.L., Pagliara A.S., Chase L.R., Kipnis D.M. Radioimmunoassay for cyclic nucleotides. II. Adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in mammalian tissues and body fluids. Journal of Biological Chemistry. 247:(4):1972;1114-1120.
34. +-ATPase. Biochimica et Biophysica Acta. 988:1989;185-220.
35. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Research. 548:1991;100-110.
36. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology. 151:2000;99-120.
37. Wang X., Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. Journal of Neurochemistry. 68:1997;443-456.
38. Witt J.J., Roskoski R. Jr. Rapid protein kinase assay using phosphocellulose-paper absorption. Analytical Biochemistry. 66:(1):1975;253-258.
39. +-ATPase as a signal transducer. European Journal of Biochemistry. 269:2002;2434-2439.